MYND Lifesciencs Inc. (MYNDF)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
As of 09:30AM EST. Market open.
| Previous Close | 0.1754 |
| Open | 0.1754 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 0.1754 - 0.1754 |
| 52 Week Range | 0.1610 - 1.1000 |
| Volume | |
| Avg. Volume | 545 |
| Market Cap | 10.481M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0000 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Baystreet
Stocks in play: MYND Life Sciences Inc
Today announced that it has entered into Collaborative Research Agreement (the "Agreement") with the ...
- CNW Group
MYND Life Sciences Announces Collaborative Research Agreement with the University of British Columbia
MYND Life Sciences Inc. ("MYND" or the "Company") (CSE: MYND) (OTC: MYNDF) a biopharmaceutical research and development company creating innovative precision medicines for patients with relentless neurological diseases, today announced that it has entered into Collaborative Research Agreement (the "Agreement") with the University of British Columbia ("UBC") focussing on Novel Therapies for Neurological Diseases.
- Baystreet
Stocks in play: MYND Life Sciences
Is pleased to announce it has successfully closed on the previously announced transaction to acquire ...
